CP and COVID-19: Authorized under the EUA for the treatment of hospitalized patients with COVID-19 and impaired immunityCareful history should be taken for previous transfusion reactionsMonitor vital signs before, during, and after infusionPatients with cardiac disease may require lower volume and slower infusionLow-titer CP should not be used